Bethenny Frankel said she "brought home a bacterial infection" after prematurely leaving her St. Barths vacation, where she ...
Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss ...
Novo Nordisk launched the first GLP-1 weight-loss pill Monday with a pledge that manufacturing investments will enable the drugmaker to avoid the type of shortages that plagued the rollout of its ...
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...
For many of these uses, the scientific backing is far weaker than that for GLP-1 drugs. Yet many users extrapolate from the ...
Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk ...
The Beijing Tongren Hospital's oculoplastic department on Sunday issued the first prescription for Sycume, a thyroid eye ...
OpenAI develops automated attacker system to test ChatGPT Atlas browser security against prompt injection threats and ...
By Daniel McKenzie Injection wells on the surface are easy to miss, just a pipe and a bunch of knobs. Beneath that simple exterior lies an intricately designed and heavily regulated engineering feat ...
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.
Researchers discovered a security flaw in Google's Gemini AI chatbot that could put the 2 billion Gmail users in danger of being victims of an indirect prompt injection attack, which could lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback